Macular Degeneration

Macular degeneration is the progressive deterioration of a critical region of the retina called the macula. The macula is a 3-5 mm area in the retina that is responsible for central vision. This disorder leads to irreversible loss of central vision, although peripheral vision is retained. In the early stages, vision may be gray, hazy, or distorted.

Macular Degeneration - most related articles:

- New gene identified for age related macular degeneration AMD - 9.5
- Macular degeneration cases would rise in near future - 9
- Age related macular degeneration AMD affects 1 million Canadians - 8.5
- Genes involved in inflammation may hold clue to age-related macular degeneration - 7.1
- Vitamin D levels linked to age related macular degeneration AMD - 6.9
- Compstatin - new drug for vision loss, macular degeneration - 6.8
- Stem cells may rescue vision in AMD patients - 6.7
- US company starts clinical trial using stem cells to treat macular degeneration - 6.1
- Aspirin may protect from AMD vision loss - 5.5
- Controlling inflammation in macular degeneration prevents progress of AMD - 5.2

Macular Degeneration articles

Controlling inflammation in macular degeneration prevents progress of AMD
Scientists at Trinity College Dublin have discovered that a part of the immune system called the inflammasome is involved in regulating the development of one of the most common forms of blindness, called Age-Related Macular Degeneration (AMD).

Eylea approved for AMD eye disorder in older people
The U.S. Food and Drug Administration approved Eylea (aflibercept) to treat patients with wet (neovascular) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older.

Vitamin D levels linked to age related macular degeneration AMD
Women under the age of 75 with high vitamin D status were less likely to have early age-related macular degeneration (AMD), the leading cause of irreversible vision loss in adults, a University at Buffalo study has shown.

AMD prevalence lowered in US
An estimated 6.5 percent of Americans age 40 and older have the eye disease age related macular degeneration, a lower rate than was reported 15 years ago, according to a report in the Archives of Ophthalmology.

US company starts clinical trial using stem cells to treat macular degeneration
Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC) announced that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world.

Age related macular degeneration AMD affects 1 million Canadians
Dr. Jean-Daniel Arbour and Dr. Pierre Labelle of the Université de Montréal Department of Ophthalmology, along with two colleagues from France, have authored a new book to prevent vision loss, AMD: Age-Related Macular Degeneration (Annika Parance Publisher; 121 pages).

Smoking increases AMD risk even after age 80
Smoking, even after age 80, continues to increase one's risk for age-related macular degeneration (AMD), the leading cause of blindness in Americans over 65.

Stem cells may rescue vision in AMD patients
An international team of scientists has rescued visual function in laboratory rats with eye disease by using cells similar to stem cells. The research shows the potential for stem cell-based therapies to treat age-related macular degeneration in humans.

Aspirin may protect from AMD vision loss
Low dose Aspirin may offer mild protection from age related Macular degeneration (AMD), revealed by researchers.

Cataract surgery does not progress AMD
Age related macular degeneration does not appear to progress at a higher rate among individuals who have had surgery to treat cataract, revealed by researchers.

Antioxidant supplement CARMA improves vision in AMD
The antioxidant nutritional supplement may help those affected by the leading cause of blindness in the Western World, a five-year research programme has found.

Down syndrome patients have a reduced risk for cancer
Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population.

Saffron has remarkable effects on eye vision
The herb saffron may hold one of the keys to preventing the loss of sight in old age – and may even help to improve vision in people suffering certain blinding eye diseases.

Eating fish, nuts, olive oil reduce AMD risk
Regularly eating fish, nuts, olive oil and other foods containing omega-three fatty acids and avoiding trans fats appears to be associated with a lower risk for the eye disease age-related macular degeneration, according to two reports in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

UCL–Pfizer to develop stem cell sight therapies
UCL has entered into a collaboration with the biopharmaceutical group Pfizer, negotiated by UCL Business, to advance development of stem cell-based therapies for age-related macular degeneration (AMD).

Macular degeneration cases would rise in near future
Health care providers can expect a significant increase in age-related macular degeneration as the baby boom generation reaches retirement age, according to a new study by researchers at RTI International and the Centers for Disease Control and Prevention.

New gene identified for age related macular degeneration AMD
A new genetic association is established with the eye condition age-related macular degeneration (AMD), revealed by researchers.

Eat oily fish to protect your eyesight in old age
Eating oily fish once a week may reduce age-related macular degeneration (AMD) which is the major cause of blindness and poor vision in adults in western countries and the third cause of global blindness, according to a study published in the American Journal of Clinical Nutrition.

Protein Robo4 may reverse macular degeneration, diabetic retinopathy
Two major eye diseases and leading causes of blindness-age-related macular degeneration and diabetic retinopathy-can be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study.

Genes involved in inflammation may hold clue to age-related macular degeneration
A University of Southampton research team, led by Professor Andrew Lotery, has identified a new genetic risk factor for age-related macular degeneration (AMD), a major cause of untreatable blindness in elderly people in developed countries.

Compstatin - new drug for vision loss, macular degeneration
University of Florida UF scientists are testing the safety of experimental drug Compstatin for vision loss in macular degeneration patients. In a first-of-its-kind safety research study, University of Florida researchers have injected an anti-inflammatory compound into the eye of a person with a sight-robbing disease.

21 Macular Degeneration articles listed above.

What is Macular Degeneration
Macular degeneration is the progressive deterioration of a critical region of the retina called the macula. The macula is a 3-5 mm area in the retina that is responsible for central vision. This disorder leads to irreversible loss of central vision, although peripheral vision is retained. In the early stages, vision may be gray, hazy, or distorted.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.56